Price T Rowe Associates Inc Catalent, Inc. Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Catalent, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 285,163 shares of CTLT stock, worth $16.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
285,163
Previous 4,909,943 94.19%
Holding current value
$16.9 Million
Previous $276 Million 93.74%
% of portfolio
0.0%
Previous 0.03%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$56.16 - $60.96 $260 Million - $282 Million
-4,624,780 Reduced 94.19%
285,163 $17.3 Million
Q2 2024

Aug 14, 2024
SELL
$53.58 - $57.02 $12.6 Million - $13.4 Million
-234,275 Reduced 4.55%
4,909,943 $276 Million
Q1 2024

May 15, 2024
SELL
$42.56 - $59.82 $140 Million - $196 Million
-3,283,122 Reduced 38.96%
5,144,218 $290 Million
Q4 2023

Feb 14, 2024
BUY
$32.18 - $46.57 $77.5 Million - $112 Million
2,408,236 Added 40.01%
8,427,340 $379 Million
Q3 2023

Nov 14, 2023
BUY
$44.2 - $50.2 $159 Million - $180 Million
3,595,039 Added 148.31%
6,019,104 $274 Million
Q2 2023

Aug 14, 2023
BUY
$31.86 - $67.26 $20.6 Million - $43.5 Million
646,674 Added 36.38%
2,424,065 $105 Million
Q1 2023

May 15, 2023
SELL
$45.44 - $74.26 $12.7 Million - $20.7 Million
-279,416 Reduced 13.58%
1,777,391 $117 Million
Q4 2022

Feb 14, 2023
BUY
$41.39 - $81.0 $5.14 Million - $10.1 Million
124,115 Added 6.42%
2,056,807 $92.6 Million
Q3 2022

Nov 14, 2022
SELL
$72.36 - $113.1 $1.47 Billion - $2.3 Billion
-20,370,869 Reduced 91.33%
1,932,692 $140 Million
Q2 2022

Aug 15, 2022
BUY
$87.2 - $114.05 $175 Million - $229 Million
2,011,520 Added 9.91%
22,303,561 $2.39 Billion
Q1 2022

May 16, 2022
BUY
$94.19 - $124.49 $158 Million - $209 Million
1,675,559 Added 9.0%
20,292,041 $2.25 Billion
Q4 2021

Feb 14, 2022
SELL
$119.57 - $139.07 $7.85 Million - $9.13 Million
-65,681 Reduced 0.35%
18,616,482 $2.38 Billion
Q3 2021

Nov 15, 2021
SELL
$109.17 - $142.35 $39.2 Million - $51.2 Million
-359,414 Reduced 1.89%
18,682,163 $2.49 Billion
Q2 2021

Aug 16, 2021
SELL
$100.34 - $115.69 $18.8 Million - $21.6 Million
-186,931 Reduced 0.97%
19,041,577 $2.06 Billion
Q1 2021

May 17, 2021
SELL
$101.51 - $125.27 $114 Million - $141 Million
-1,123,347 Reduced 5.52%
19,228,508 $2.02 Billion
Q4 2020

Feb 16, 2021
BUY
$85.88 - $105.36 $1.75 Billion - $2.14 Billion
20,351,855 New
20,351,855 $2.12 Billion

Others Institutions Holding CTLT

# of Institutions
512
Shares Held
149M
Call Options Held
575K
Put Options Held
2.03M
View Full List

About Catalent, Inc.

CTLT Quotes by TradingView
  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.6B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email